USP44 Antibodies

Santa Cruz Biotechnology provides a broad selection of USP44 monoclonal antibodies for investigating USP44 in cellular processes. USP44 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USP44, or Ubiquitin Specific Peptidase 44, is a deubiquitinating enzyme that maintains protein stability and regulates cellular signaling pathways. USP44 functions are essential in cell cycle regulation and DNA damage response, making it a key target for cancer research and therapeutic development. Research has shown that USP44 activity influences multiple cellular pathways involved in normal development and disease progression. Understanding USP44 mechanisms can reveal new approaches for treating various cancers and disorders. Ongoing studies continue to uncover novel functions of USP44 in cellular homeostasis and disease states. USP44 research using Santa Cruz Biotechnology monoclonal antibodies enables scientists to advance our understanding of cancer biology and develop innovative therapeutic strategies.